View Older Stories
-
Thermo Fisher beats fourth-quarter expectations, shares climb
-
Thermo Fisher Scientific (TMO) Tops Q4 EPS by 12c
-
Thermo Fisher Scientific announces executive departures and leadership changes
-
HSBC lists 11 potential U.S. outperformers heading into earnings
-
Thermo Fisher Scientific (TMO) PT Raised to $700 at Stifel
-
Thermo Fisher Scientific (TMO) puts more active than calls into the annual J.P. Morgan Healthcare Conference
-
Citi Adjusts Large Cap Recommended List, Micron (MU) Removed
-
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
-
Goldman Sachs Starts Thermo Fisher Scientific (TMO) at Buy
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
KeyBanc Upgrades Thermo Fisher Scientific (TMO) to Overweight
-
Thermo Fisher Scientific expands bioprocess centers across Asia
-
Morgan Stanley Assumes Thermo Fisher Scientific (TMO) at Overweight
-
Thermo Fisher gets FDA clearance for multiple myeloma diagnostic system
-
Thermo Fisher authorizes $5 billion share repurchase program
-
Thermo Fisher Scientific (TMO) Declares $0.43 Quarterly Dividend; 0.3% Yield
-
Thermo Fisher Scientific (TMO) Nears Takeover Of Clario At About $10 bln Value- FT
-
Thermo Fisher Scientific (TMO) PT Raised to $654 at TD Cowen
-
Thermo Fisher Scientific (TMO) PT Raised to $610 at Evercore ISI
-
Thermo Fisher Scientific (TMO) Tops Q3 EPS by 29c
-
Thermo Fisher Scientific earnings preview Q3: stronger print expected amid life sciences recovery
-
Thermo Fisher Scientific partners with OpenAI to speed drug development
-
KeyBanc Reiterates Sector Weight Rating on Thermo Fisher Scientific (TMO)
-
Thermo Fisher Scientific (TMO) call put ratio 10.1 calls to 1 put with a focus on November calls
-
Bernstein on Thermo Fisher Scientific (TMO): 'Is Now the Time To Invest?... Buy the Strength'
-
Bernstein Reiterates Outperform Rating on Thermo Fisher Scientific (TMO)
-
Barclays Upgrades Thermo Fisher Scientific (TMO) to Overweight
-
William Blair Starts Thermo Fisher Scientific (TMO) at Outperform
-
Bernstein on Thermo Fisher Scientific (TMO): 'Buy the Strength'; PT Raised
-
HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold
-
Thermo Fisher Scientific (TMO) PT Lowered to $583 at Stifel
-
Thermo Fisher Scientific (TMO) call put ratio 3.4 calls to 1 put with a focus on October calls as share price up 10%
-
Thermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Beats on Revenue
-
Thermo Fisher Scientific (TMO) PT Lowered to $550 at TD Cowen
-
Thermo Fisher to acquire Sanofi's New Jersey manufacturing site
-
Scotiabank Upgrades Thermo Fisher Scientific (TMO) to Sector Outperform
-
Thermo Fisher Scientific (TMO) Declares $0.43 Quarterly Dividend; 0.4% Yield
-
UBS Downgrades Thermo Fisher (TMO) to Neutral
-
Evercore Lists Additions to TAP Outperform List of Life Science & Diagnostic Tools Names
-
Bernstein on US Life Science Tools & Diagnostics: 'Why We're More Bullish...'
-
Adial Pharmaceuticals (ADIL) partners with Cambrex and Thermo Fischer (TMO) for AD04
-
908 Devices (MASS) Appoints Christopher D. Brown to its Board of Directors
-
Thermo Fisher Scientific (TMO) Declares $0.43 Quarterly Dividend; 0.4% Yield
-
Charles River to initiate a review amid Elliott stake - Is a sale next?
-
Thermo Fisher Scientific (TMO) call put ratio 1 call to 2.2 puts
-
Thermo Fisher Scientific (TMO) PT Lowered to $605 at Scotiabank
-
Thermo Fisher Scientific (TMO) Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing
-
Thermo Fisher Scientific tops Q1 estimates, shares rise
-
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 4c
-
Qiagen (QGEN) said targeted by activist Fivespan Partners

